Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
68.53 BRL | -5.23% |
|
-5.23% | -0.91% |
11:02am | Hutchmed China notes Takeda obtains EU approval for Fruzaqla | AN |
10:45am | Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- 4502 Stock
- TAKP34 Stock
- Revisions Takeda Pharmaceutical Company Limited